HOME
ABOUT
About US
Corporate culture
Company honor
Development course
PRODUCT
Drugs in the field of tumor-re
Drugs in other fields
Health care products
R&d innovation
R&d pipeline
R&d progress
Patient recruitment
NEWS
Company dynamics
Trade news
Academic exchanges
INVESTOR
Latest announcement
H&R
Job development
Talent recruitment
CONTACT
Notice
EN
CN
HOME
ABOUT
About US
Corporate culture
Company honor
Development course
PRODUCT
Drugs in the field of tumor-re
Drugs in other fields
Health care products
R&d innovation
R&d pipeline
R&d progress
Patient recruitment
NEWS
Company dynamics
Trade news
Academic exchanges
INVESTOR
INVESTOR
Latest announcement
H&R
Job development
Talent recruitment
CONTACT
Notice
Expert Consensus on the Use of Proprietary Chinese Medicines for the Inclusion of Shengbai Oral Liquid in Palliative Treatment of Tumors (2013 Edition)
2019-08-27
PREV
Meta-analysis of the efficacy of Shengbai mixture in the treatment of tumor chemotherapy induced by bone marrow suppression
NEXT
Shengbai oral liquid was included in the guidelines for the diagnosis and treatment of malignant tumors in traditional Chinese medicine
Hot news
What kind of treatment is needed fo...
Shengbai Oral Liquid (Mixture) w...
Should leukopenia be discontinued i...
How to deal with leukopenia after c...
How much do you know about leukopen...
Shengbai oral liquid (mixture) was ...
Shengbai Oral Liquid (Mixture) w...
Meta-analysis of the efficacy of S...